Back to VRSK
VRSK Research: Valuation, Earnings & Risks
$VRSKNEUTRALTechnology

VRSK Research: Valuation, Earnings & Risks

Verisk’s latest reported quarter beat EPS estimates, while recent analyst actions include higher targets from Barclays and Wells Fargo. Modest growth, a premium valuation and negative book equity complicate the picture for VRSK.

November 14, 202610 min read
Current Price
$207.82
+0.73%
Analyst Rating
Buy
Price Target
$225.63
8.6% upside
P/E Ratio
31.49

Executive Summary

Investment Thesis: Verisk Analytics sells data, analytics and decision-support tools to insurance and related markets, a business model that benefits from specialized information and recurring customer needs. Its latest reported EPS of $1.96 exceeded the $1.92 estimate, and recent analyst actions included target increases. However, reported revenue growth of 5.3% and earnings growth of 5.4% are measured, while the stock’s valuation remains substantial and negative book equity makes some balance-sheet ratios hard to interpret. The overall evidence is mixed rather than decisive.

Current Price: $207.82, supplied quote reference; U.S. markets were closed Saturday, November 14 | Key Metric: Forward P/E 23.87 | Stance: NEUTRAL

The supplied quote shows a change of $1.50, or 0.73%, from a stated previous close of $206.32. Because the report date is Saturday, that change is not Saturday trading; the materials don’t establish the exact session attached to the quote. For context, the next U.S. trading session is Monday, November 16.

Company Overview

Verisk Analytics provides data, analytics and technology services, with a significant focus on the insurance industry. Customers use its information and analytical tools in areas such as risk assessment, underwriting, claims and catastrophe analysis. These services can become part of a customer’s recurring workflow, though the company still must demonstrate that its tools deliver value as customer needs and competing technologies change.

Key Products & Competitive Position

  • Core Business: Data, analytics and software services that help insurance and related businesses assess risk and make operational decisions.
  • Key Products: Insurance-industry data and analytics, risk and catastrophe modeling, and solutions supporting underwriting and claims workflows. The supplied material does not provide product-level revenue or growth.
  • Competitive Moat: Specialized datasets, analytical expertise and integration into customer processes may support customer retention and recurring revenue. The strength of that advantage depends on data quality, product relevance and customers’ willingness to continue paying for the services.

Recent Developments

The latest supplied earnings report, dated November 5, 2026, showed EPS of $1.96 against an estimate of $1.92. On November 6, Barclays raised its price target to $250 from $225 while maintaining Overweight, and Wells Fargo raised its target to $265 from $260, also maintaining Overweight. Earlier, on October 13, BMO Capital and Morgan Stanley lowered their respective targets, a reminder that analyst views have not moved uniformly.

Financial Snapshot

Market Cap$26.66B
P/E Ratio31.49
52-Week Range$155.94 - $227.16
Dividend Yield0.94%
EPS (TTM)$6.81
ROE-111.25%

Revenue & Earnings Trends

Yahoo Finance data in the supplied research lists trailing revenue of approximately $3.18 billion, revenue growth of 5.3%, earnings growth of 5.4%, and net income to common of approximately $879 million. Gross margin was 70.17%, operating margin 44.97%, and EBITDA margin 48.38%. Those margins indicate a profitable operation, but the reported growth rates are not rapid enough on their own to remove questions about the price investors are paying for that growth.

The November 5 EPS result beat consensus by $0.04, or about 2.1% of the estimate. One quarterly beat is a positive data point, not proof of a continuing acceleration. The supplied information does not include the quarter’s revenue result, detailed year-over-year comparisons, or management’s full guidance, so those aspects can’t be independently assessed here.

Balance Sheet Highlights

Reported cash was approximately $557.6 million against total debt of $4.63 billion, implying net debt of roughly $4.08 billion. Operating cash flow was approximately $1.37 billion and free cash flow approximately $937 million, which provide context for the company’s capacity to service debt and fund its business. The current ratio of 1.07 and quick ratio of 0.95 point to limited short-term balance-sheet headroom relative to a more cash-rich profile.

ROE of -111.25% and book value per share of -$8.68 require caution. Negative equity can make return-on-equity and price-to-book ratios unhelpful or misleading; a negative P/B ratio is not a conventional signal that a stock is inexpensive. The supplied data do not explain the drivers of negative equity, so investors reviewing the company’s filings would need to examine its capital allocation and balance-sheet history.

Valuation Analysis

Current Valuation Metrics

Forward P/E23.87Industry comparison not supplied
PEG Ratio4.42*Approximate, using 5.4% earnings growth
EV/EBITDA20.0Historical comparison not supplied
P/S Ratio8.4Peer comparison not supplied

*The PEG figure is a rough calculation using the reported forward P/E and trailing earnings growth. It is not a company forecast and can change materially if expected growth differs. EV/EBITDA is calculated from supplied enterprise value of approximately $30.74 billion and EBITDA of approximately $1.54 billion. P/S uses market capitalization of $26.66 billion and trailing revenue of approximately $3.18 billion.

Historical Comparison

The supplied research does not provide five-year average valuation multiples, so a like-for-like comparison with Verisk’s own historical P/E or EV/EBITDA cannot be made responsibly. Yahoo Finance’s extracted data reports an average closing price of $234.27 over two years and a two-year total return of -26.19%. Those price observations are not substitutes for a valuation history, but they do show that the current reference quote sits below that reported average closing price.

Fair Value Estimate

A precise intrinsic-value estimate would require assumptions about future cash flow growth, discount rates, margins, reinvestment and debt. Those inputs aren’t provided, so a DCF point estimate would create false precision. Multiples offer a limited cross-check: a forward P/E of 23.87 and EV/EBITDA near 20 imply that the market assigns meaningful value to continued profitability and customer demand. The valuation case becomes more sensitive if growth slows or margins compress.

Competitive Landscape

Market Position

Market Share: Not quantified in the supplied data | Ranking: Not independently specified in the supplied data

Key Competitors

MSCI (MSCI)Provides data, analytics and risk-related tools across financial markets and other industries, with a different business mix.
S&P Global (SPGI)Offers financial information, analytics and ratings; it competes in selected data and analytics needs, not across every Verisk product.
$FDSSupplies financial data and analytics solutions, serving overlapping information-service needs in distinct customer markets.

Competitive Advantages

  • Specialized Information: Insurance-focused datasets and analytical experience can be difficult for a new entrant to reproduce quickly.
  • Workflow Integration: Tools embedded in underwriting, risk and claims processes may create switching costs, although customer retention data were not supplied.
  • Cash Generation: Reported free cash flow of approximately $937 million provides a financial resource for operations, investment and capital allocation.

The named companies are broad information-services comparables, not exact substitutes for every Verisk product. The supplied data do not quantify Verisk’s market share or establish a precise industry ranking, so stronger claims about leadership would require additional evidence.

Earnings Track Record

Last 4 Quarters: 1 documented beat / 0 documented misses; 3 quarters without supplied results

Recent Earnings History

Q3 2026, reported Nov. 5$1.96 vs $1.92 estBEAT
Q2 2026Actual and estimate not suppliedN/A
Q1 2026Actual and estimate not suppliedN/A
Q4 2025Actual and estimate not suppliedN/A

Guidance Trend

No specific management guidance figures or revisions were included in the supplied research. The latest EPS beat and the reported 5.3% revenue and 5.4% earnings growth provide useful context, but they don’t establish the direction of future guidance. Investors following the next results can compare management’s outlook with realized revenue growth, margins, cash conversion and customer demand.

Analyst Sentiment

Consensus Rating: Buy, according to the supplied analyst summary

Strong Buy: 4 Buy: 7 Hold: 8 Sell: 0

The supplied breakdown covers 19 analysts and also lists zero Strong Sell ratings. It is a third-party opinion snapshot, not a guarantee of returns or a substitute for evaluating the underlying business. Another supplied Yahoo Finance extract reports 17 analyst opinions and a different mean target, so the datasets appear to use different coverage counts or update timing.

Price Targets

  • Low: $185
  • Mean: $225.63, approximately 8.6% above the $207.82 reference quote
  • High: $247

The alternate Yahoo Finance extract lists a $195 low, $235.94 mean and $265 high from 17 opinions. This difference is material: the two reported mean targets imply different potential returns from the same reference quote. Treat the target range as an analyst expectation snapshot with source and timing uncertainty, not as a price forecast established by this report.

Recent Analyst Actions

On November 6, Barclays maintained Overweight and increased its target from $225 to $250; Wells Fargo maintained Overweight and raised its target from $260 to $265. On October 13, BMO Capital maintained Outperform but lowered its target from $248 to $217, while Morgan Stanley maintained Equal-Weight and cut its target from $235 to $215. The mixed sequence suggests that analysts differ on how to value the company’s growth and risk profile.

Recent News & Catalysts

Key Developments

  • Latest EPS Beat: Verisk reported $1.96 per share on November 5, compared with a $1.92 estimate, a 4-cent beat. The supplied report does not include a complete revenue or guidance comparison.
  • Target Changes: Barclays and Wells Fargo raised targets on November 6, while BMO Capital and Morgan Stanley had lowered targets on October 13. Rating stances were maintained in each listed action.
  • Cash Flow and Leverage: Reported free cash flow of approximately $937 million is notable alongside roughly $4.63 billion of total debt and $558 million of cash. The balance between cash generation, debt service and capital allocation merits continued attention.

Upcoming Catalysts

Next Earnings: Date not supplied; the latest report was November 5, 2026 | Key Events: Next quarterly results and guidance, trends in insurance-sector demand, cash flow and leverage, and any further analyst estimate revisions

Markets are closed over the weekend, with the next U.S. session scheduled for Monday, November 16. No specific company event for that week was identified in the supplied research.

Technical Outlook

Current Price: $207.82 reference quote vs 52-Week High: $227.16, approximately 8.5% below the high

Trend Analysis

The reference quote is within the stated 52-week range of $155.94 to $227.16, closer to the high than the low in absolute price terms. The reported two-year average closing price of $234.27 is above the current reference quote, and the supplied two-year total return is -26.19%. Those figures provide longer-period context but do not establish the short-term trend; no moving averages, relative-strength readings or trading-volume details for the latest session were supplied.

Key Levels

  • Resistance: Approximately $211.24, the supplied day-range high, and $227.16, the 52-week high
  • Support: Around $200 as a round-number reference, then $185, the low end of the primary analyst target range; neither is confirmed as technical support by supplied chart data

These levels are reference points, not assurances that the price will stop or reverse at those values. The data also provide no verified support or resistance tests, so short-term signals should be treated cautiously.

Bull vs Bear Case

Bull Case

  • Recent Results: The latest reported EPS exceeded estimates, and the company reported substantial operating and free cash flow.
  • Recurring Information Needs: Insurance customers’ ongoing needs for risk data and analytics may support durable demand if Verisk maintains product quality and relevance.
  • Analyst Targets: The primary supplied analyst mean is $225.63, with a high of $247. These are analyst reference points, not this report’s forecast.

Bull Target Reference: $247, the high of the supplied primary analyst range, not an independent estimate

Bear Case

  • Valuation Sensitivity: A forward P/E of 23.87 and EV/EBITDA near 20 leave the valuation sensitive to slower growth or weaker margins.
  • Leverage and Equity: Total debt substantially exceeds cash, while negative book value and ROE complicate balance-sheet comparisons.
  • Moderate Growth and Mixed Views: Reported revenue and earnings growth are near 5%, and analyst targets have been both raised and cut. The two supplied target datasets also conflict.

Bear Target Reference: $185, the low of the supplied primary analyst range, not an independent estimate

Risks to Consider

  • Valuation Risk: The market multiple may be difficult to sustain if revenue growth, earnings growth or margins weaken. The PEG approximation is particularly sensitive to the growth assumption used.
  • Competitive Risk: Data providers, insurers’ internal analytics teams and newer technology platforms may compete for customer budgets. The supplied material does not quantify customer retention or switching costs.
  • Macro Risk: Changes in insurance pricing, claims activity, catastrophe losses and customer spending can affect demand for risk-related tools. No quantified sensitivity analysis was provided.
  • Execution Risk: Maintaining trusted datasets, effective analytical products and dependable customer workflows requires ongoing investment. Leverage and a current ratio of 1.07 are also factors to monitor alongside cash generation.

Bottom Line

Investment Verdict: NEUTRAL

Verisk combines high reported margins, positive cash generation and a recent modest EPS beat with measured growth, substantial valuation multiples and balance-sheet features that warrant closer review. Analyst opinions lean positive in the supplied breakdown, but their target estimates vary across sources and do not resolve the valuation uncertainty. This report is informational analysis, not investment advice.

Action Items for Investors

  • Long-term investors: Track revenue and earnings growth, customer demand, free cash flow and debt trends against the valuation being assigned to those results. The supplied figures alone do not establish a personalized course of action.
  • Short-term traders: Distinguish the Saturday report date from market sessions, and treat the quoted day range and approximate price levels as context rather than confirmed technical signals. The next U.S. session is Monday, November 16.
  • Risk management: Account for uncertainty in analyst targets, the lack of a complete four-quarter earnings history in the supplied data, and negative book equity when comparing VRSK with other companies.

What to Watch This Week

  • How the reference price behaves when U.S. trading resumes Monday, November 16, without assuming the supplied quote reflects Saturday activity.
  • Any company updates, guidance details or analyst estimate changes following the November 5 earnings report.
  • Whether future disclosures show continued cash generation alongside manageable debt and steady operating performance.

Share this report

Share this article

Spread the word on social media

Think VRSK will outperform? Prove it.

Free practice contests — earn Alpha Coins
Enter a Contest

Disclaimer: StockAlpha.ai content is for informational and educational purposes only. It is not personalized investment advice. Sentiment ratings and market analysis reflect data-driven observations, not buy, sell, or hold recommendations. Always consult a qualified financial advisor before making investment decisions. Past performance does not guarantee future results.

Spotted something wrong? Report an error.